The insulin delivery devices market is expected to reach US$16.8744 billion by 2024 from US$11.231 billion in 2018 growing at a CAGR of 7.02%. Insulin Delivery Devices are used to administer insulin to the diabetic patients. There are many different types of insulin delivery devices available including syringes, delivery devices, jet injectors, oral insulin and pumps etc. giving patients number of options to decide as per their ease and convenience. Alternate forms of insulin delivery are being developed to overcome problems with current subcutaneous insulin injection therapy like poor compliance due to pain, variable absorption lack of feedback control. Insulin Delivery Devices market will show robust growth during the forecast period owing to the rising prevalence of the diabetes because of sedentary life style and rising number of geriatric population across the globe. Continuous technological innovations and advancements in insulin delivery devices for increasing patient compliance will also boost the adoption of the Insulin Delivery Devices during the given forecast period. Poor reimbursement structure and insurance coverage in developing countries might restrain the growth of the Insulin Delivery Devices market during the given time frame.
The Insulin Delivery Devices Market – Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by types, application, end users and geography.
The insulin delivery devices market has been segmented based on by types, application, and geography. By types, the market is segmented as insulin pens, syringes, insulin pumps, inhalers and others. By application, market is segmented as type I diabetes, type II diabetes and gestational diabetes. On the basis of end users market is segmented as hospitals and clinics, ambulatory care settings and home care settings.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major industry players profiled as part of the report are Beiersdorf Australia Ltd., Breg, Inc., Custom Ice, DJO, LLC, Hisamitsu Pharmaceutical Co., Inc and Johnson & Johnson Services, Inc. among others.
Insulin Delivery devices
Type I Diabetes
Type II Diabetes
By End Users
Hospitals and Clinics
Ambulatory Care Settings
Home Care Settings
Middle East and Africa